Please assess the completion status of the following clinical trial:

Trial Title: A Clinical Pharmacological Study of Rabeprazole Sodium in Japanese Healthy Adult Male Volunteers (Study E3810)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* healthy adult Japanese male between the age of 20-40~* body mass index between 18.5-25~Exclusion Criteria:~* clinically significant abnormal physical examination, vital signs or electrocardiogram~* use of any prescription medication, antacid, nutritional supplement, vitamin preparation, or herb-containing drug within the previous 4 weeks~* use of any non-prescription medication within the previous 1 week~* history of drug or alcohol abuse

- Gender: MALE
- Minimum Age: 20 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- Rabeprazole sodium Tablets, 5 mg (Type: EXPERIMENTAL): None
- Rabeprazole sodium Tablets, 10 mg (Type: EXPERIMENTAL): None
- Rabeprazole sodium Tablets, 20 mg (Type: EXPERIMENTAL): None
- Rabeprazole sodium Tablets, 40 mg (two 20 mg Tablets) (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).